| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Non-Small-Cell Lung | 24 | 2023 | 350 | 5.850 |
Why?
|
| Lung Neoplasms | 40 | 2024 | 1660 | 5.730 |
Why?
|
| Esophageal Neoplasms | 15 | 2024 | 375 | 4.110 |
Why?
|
| Mesothelioma | 8 | 2024 | 88 | 3.420 |
Why?
|
| Pneumonectomy | 15 | 2022 | 143 | 2.980 |
Why?
|
| Esophagectomy | 10 | 2024 | 64 | 2.630 |
Why?
|
| Adenocarcinoma | 12 | 2024 | 1026 | 2.300 |
Why?
|
| Neoplasm Staging | 29 | 2023 | 1276 | 2.180 |
Why?
|
| Pleural Neoplasms | 6 | 2024 | 71 | 1.900 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2023 | 33 | 1.630 |
Why?
|
| Lymphatic Metastasis | 14 | 2024 | 418 | 1.620 |
Why?
|
| Thoracic Surgical Procedures | 4 | 2020 | 102 | 1.490 |
Why?
|
| Lymph Nodes | 10 | 2017 | 379 | 1.360 |
Why?
|
| Neoadjuvant Therapy | 6 | 2022 | 341 | 1.280 |
Why?
|
| Esophageal Perforation | 4 | 2024 | 15 | 1.190 |
Why?
|
| Thoracoscopy | 4 | 2021 | 43 | 0.940 |
Why?
|
| Surgical Flaps | 3 | 2021 | 203 | 0.920 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2023 | 363 | 0.870 |
Why?
|
| SEER Program | 8 | 2019 | 202 | 0.860 |
Why?
|
| Radiosurgery | 2 | 2022 | 111 | 0.840 |
Why?
|
| Neoplasm Grading | 2 | 2023 | 272 | 0.830 |
Why?
|
| Humans | 105 | 2024 | 125138 | 0.800 |
Why?
|
| Bronchial Fistula | 4 | 2012 | 22 | 0.760 |
Why?
|
| Endosonography | 4 | 2012 | 79 | 0.750 |
Why?
|
| Positron-Emission Tomography | 4 | 2020 | 306 | 0.740 |
Why?
|
| Hernia, Diaphragmatic | 3 | 2011 | 98 | 0.740 |
Why?
|
| Pleural Diseases | 3 | 2009 | 28 | 0.730 |
Why?
|
| Biopsy, Fine-Needle | 5 | 2012 | 117 | 0.730 |
Why?
|
| Funnel Chest | 1 | 2021 | 34 | 0.700 |
Why?
|
| Metastasectomy | 1 | 2020 | 10 | 0.700 |
Why?
|
| Respiratory Paralysis | 2 | 2010 | 7 | 0.680 |
Why?
|
| Ketorolac | 1 | 2020 | 13 | 0.670 |
Why?
|
| Stomach | 1 | 2021 | 270 | 0.610 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2019 | 70 | 0.600 |
Why?
|
| Treatment Outcome | 26 | 2024 | 12392 | 0.600 |
Why?
|
| Databases, Factual | 3 | 2019 | 1179 | 0.590 |
Why?
|
| Health Services Research | 1 | 2019 | 186 | 0.590 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2021 | 1142 | 0.580 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 183 | 0.570 |
Why?
|
| Internship and Residency | 5 | 2021 | 1181 | 0.570 |
Why?
|
| Surgeons | 3 | 2021 | 257 | 0.570 |
Why?
|
| Educational Measurement | 2 | 2020 | 324 | 0.570 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 167 | 0.540 |
Why?
|
| Certification | 1 | 2017 | 67 | 0.530 |
Why?
|
| Frailty | 1 | 2019 | 106 | 0.530 |
Why?
|
| Chemoradiotherapy | 1 | 2017 | 103 | 0.530 |
Why?
|
| Registries | 3 | 2019 | 1433 | 0.510 |
Why?
|
| Respiratory Function Tests | 10 | 2010 | 198 | 0.500 |
Why?
|
| Thoracic Surgery | 5 | 2019 | 160 | 0.480 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2017 | 668 | 0.460 |
Why?
|
| Middle Aged | 49 | 2024 | 26932 | 0.460 |
Why?
|
| Postoperative Care | 3 | 2016 | 300 | 0.460 |
Why?
|
| Laparoscopy | 4 | 2020 | 493 | 0.450 |
Why?
|
| Mediastinum | 9 | 2012 | 43 | 0.450 |
Why?
|
| Anastomotic Leak | 3 | 2021 | 31 | 0.430 |
Why?
|
| Aged | 39 | 2024 | 19871 | 0.430 |
Why?
|
| Mediastinoscopy | 3 | 2009 | 5 | 0.420 |
Why?
|
| Survival Rate | 13 | 2022 | 2063 | 0.420 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 635 | 0.410 |
Why?
|
| Socioeconomic Factors | 2 | 2021 | 871 | 0.400 |
Why?
|
| Retrospective Studies | 29 | 2024 | 16333 | 0.400 |
Why?
|
| Prognosis | 8 | 2024 | 4642 | 0.400 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 1119 | 0.390 |
Why?
|
| Lung | 8 | 2022 | 1496 | 0.390 |
Why?
|
| Aged, 80 and over | 22 | 2020 | 6600 | 0.390 |
Why?
|
| Insurance, Health | 1 | 2013 | 139 | 0.380 |
Why?
|
| Insurance Coverage | 1 | 2013 | 122 | 0.380 |
Why?
|
| Ultrasonography, Interventional | 3 | 2016 | 193 | 0.370 |
Why?
|
| Cisplatin | 4 | 2023 | 249 | 0.370 |
Why?
|
| Smoking | 7 | 2008 | 1051 | 0.360 |
Why?
|
| Drainage | 6 | 2016 | 259 | 0.360 |
Why?
|
| GPI-Linked Proteins | 2 | 2024 | 101 | 0.360 |
Why?
|
| Postoperative Complications | 8 | 2016 | 3071 | 0.360 |
Why?
|
| Male | 54 | 2024 | 61493 | 0.350 |
Why?
|
| Carcinoid Tumor | 1 | 2011 | 26 | 0.350 |
Why?
|
| Appendiceal Neoplasms | 1 | 2011 | 18 | 0.350 |
Why?
|
| Esophagoscopy | 4 | 2024 | 157 | 0.350 |
Why?
|
| Colectomy | 1 | 2011 | 74 | 0.340 |
Why?
|
| Thoracic Neoplasms | 1 | 2010 | 38 | 0.340 |
Why?
|
| Appendectomy | 1 | 2011 | 86 | 0.340 |
Why?
|
| Diaphragmatic Eventration | 1 | 2009 | 7 | 0.330 |
Why?
|
| Anastomosis, Surgical | 2 | 2021 | 170 | 0.330 |
Why?
|
| Respiratory Tract Fistula | 1 | 2009 | 16 | 0.330 |
Why?
|
| Risk Factors | 9 | 2024 | 10309 | 0.330 |
Why?
|
| Diaphragm | 1 | 2010 | 98 | 0.310 |
Why?
|
| Female | 50 | 2024 | 66771 | 0.310 |
Why?
|
| Thymus Neoplasms | 2 | 2019 | 39 | 0.300 |
Why?
|
| Melanoma | 2 | 2013 | 943 | 0.300 |
Why?
|
| Mediastinal Neoplasms | 1 | 2008 | 42 | 0.300 |
Why?
|
| Hernia, Diaphragmatic, Traumatic | 1 | 2008 | 10 | 0.290 |
Why?
|
| Predictive Value of Tests | 6 | 2024 | 2174 | 0.290 |
Why?
|
| Risk Assessment | 8 | 2021 | 3465 | 0.280 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 231 | 0.270 |
Why?
|
| Device Removal | 2 | 2010 | 221 | 0.270 |
Why?
|
| Health Status Disparities | 1 | 2010 | 229 | 0.270 |
Why?
|
| Clinical Competence | 3 | 2015 | 1005 | 0.270 |
Why?
|
| Quality of Life | 4 | 2022 | 1938 | 0.260 |
Why?
|
| Neoplasms | 1 | 2021 | 2794 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2011 | 2102 | 0.250 |
Why?
|
| Reoperation | 4 | 2021 | 833 | 0.240 |
Why?
|
| United States | 12 | 2021 | 10916 | 0.240 |
Why?
|
| Chemoradiotherapy, Adjuvant | 2 | 2018 | 29 | 0.240 |
Why?
|
| Adult | 34 | 2021 | 29634 | 0.240 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 433 | 0.240 |
Why?
|
| Career Choice | 2 | 2015 | 148 | 0.220 |
Why?
|
| Hospitals, High-Volume | 2 | 2021 | 36 | 0.220 |
Why?
|
| Cytoreduction Surgical Procedures | 2 | 2022 | 42 | 0.220 |
Why?
|
| Time Factors | 12 | 2018 | 6333 | 0.220 |
Why?
|
| Biomarkers, Tumor | 2 | 2024 | 1497 | 0.210 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 946 | 0.210 |
Why?
|
| Endoscopic Mucosal Resection | 2 | 2021 | 68 | 0.200 |
Why?
|
| Patient Selection | 4 | 2015 | 699 | 0.200 |
Why?
|
| Cardiovascular Diseases | 2 | 2015 | 1968 | 0.190 |
Why?
|
| Thoracic Surgery, Video-Assisted | 4 | 2009 | 55 | 0.190 |
Why?
|
| Sternum | 1 | 2021 | 54 | 0.180 |
Why?
|
| Heart Transplantation | 1 | 2008 | 860 | 0.180 |
Why?
|
| Survival Analysis | 5 | 2017 | 1506 | 0.180 |
Why?
|
| Esophageal Motility Disorders | 1 | 2020 | 17 | 0.180 |
Why?
|
| Myotomy | 1 | 2020 | 19 | 0.170 |
Why?
|
| Respiration | 4 | 1990 | 119 | 0.170 |
Why?
|
| Regional Blood Flow | 1 | 2021 | 210 | 0.170 |
Why?
|
| Health Services Accessibility | 2 | 2019 | 607 | 0.170 |
Why?
|
| Surveys and Questionnaires | 5 | 2015 | 3732 | 0.170 |
Why?
|
| Immunotherapy | 1 | 2024 | 680 | 0.160 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 10 | 0.160 |
Why?
|
| Thymectomy | 1 | 2019 | 23 | 0.160 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 86 | 0.160 |
Why?
|
| Heart-Assist Devices | 1 | 2008 | 1025 | 0.160 |
Why?
|
| Thymoma | 1 | 2019 | 18 | 0.160 |
Why?
|
| Margins of Excision | 1 | 2019 | 51 | 0.160 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2019 | 81 | 0.150 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2019 | 39 | 0.150 |
Why?
|
| Intention | 1 | 2019 | 93 | 0.150 |
Why?
|
| Attention | 1 | 2020 | 202 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 1254 | 0.150 |
Why?
|
| Pneumothorax | 2 | 2009 | 76 | 0.150 |
Why?
|
| Thoracotomy | 2 | 2008 | 111 | 0.140 |
Why?
|
| Follow-Up Studies | 11 | 2019 | 5177 | 0.140 |
Why?
|
| Robotics | 1 | 2019 | 108 | 0.140 |
Why?
|
| Tumor Burden | 2 | 2015 | 230 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 3572 | 0.140 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 122 | 0.130 |
Why?
|
| Blood Transfusion | 1 | 2019 | 313 | 0.130 |
Why?
|
| Lymph Node Excision | 3 | 2012 | 166 | 0.130 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1896 | 0.130 |
Why?
|
| Ascites | 1 | 2016 | 88 | 0.130 |
Why?
|
| Population Surveillance | 2 | 2016 | 389 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2011 | 1055 | 0.130 |
Why?
|
| Pancreatectomy | 1 | 2016 | 138 | 0.120 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2015 | 10 | 0.120 |
Why?
|
| Esophagogastric Junction | 2 | 2020 | 33 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 614 | 0.120 |
Why?
|
| Respiration Disorders | 1 | 2015 | 32 | 0.120 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 2 | 2011 | 11 | 0.120 |
Why?
|
| Bronchoscopy | 3 | 2010 | 152 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 3 | 2017 | 620 | 0.120 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 1994 | 2 | 0.120 |
Why?
|
| Mucociliary Clearance | 1 | 1994 | 4 | 0.120 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 2056 | 0.120 |
Why?
|
| Stomach Neoplasms | 2 | 2012 | 548 | 0.120 |
Why?
|
| Cohort Studies | 7 | 2022 | 4819 | 0.110 |
Why?
|
| Endoscopy | 1 | 2016 | 281 | 0.110 |
Why?
|
| Morbidity | 1 | 2015 | 248 | 0.110 |
Why?
|
| Hematologic Diseases | 1 | 2015 | 79 | 0.110 |
Why?
|
| Probability | 3 | 2009 | 320 | 0.110 |
Why?
|
| Odds Ratio | 3 | 2013 | 1257 | 0.100 |
Why?
|
| Confidence Intervals | 2 | 2013 | 286 | 0.100 |
Why?
|
| Empyema, Pleural | 2 | 2009 | 25 | 0.100 |
Why?
|
| Esophageal Fistula | 1 | 2012 | 14 | 0.100 |
Why?
|
| Bronchi | 1 | 2012 | 97 | 0.100 |
Why?
|
| Young Adult | 5 | 2019 | 9056 | 0.100 |
Why?
|
| Barrett Esophagus | 1 | 2016 | 347 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2312 | 0.100 |
Why?
|
| Carcinoma, Small Cell | 6 | 2008 | 51 | 0.090 |
Why?
|
| Disease Management | 1 | 2015 | 527 | 0.090 |
Why?
|
| Emergencies | 1 | 2012 | 171 | 0.090 |
Why?
|
| Ultrasonography | 3 | 2010 | 941 | 0.090 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2010 | 14 | 0.090 |
Why?
|
| Incidence | 2 | 2008 | 3146 | 0.090 |
Why?
|
| Pharyngostomy | 1 | 2010 | 2 | 0.090 |
Why?
|
| Medicaid | 1 | 2013 | 243 | 0.090 |
Why?
|
| Spinal Fractures | 1 | 2010 | 38 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2012 | 227 | 0.080 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 518 | 0.080 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2010 | 53 | 0.080 |
Why?
|
| Rheumatoid Nodule | 1 | 2009 | 2 | 0.080 |
Why?
|
| Orthopedic Procedures | 1 | 2010 | 69 | 0.080 |
Why?
|
| Cervical Vertebrae | 1 | 2010 | 111 | 0.080 |
Why?
|
| Carcinoma | 1 | 2012 | 287 | 0.080 |
Why?
|
| Hospital Mortality | 2 | 2012 | 1025 | 0.080 |
Why?
|
| Decompression, Surgical | 1 | 2010 | 96 | 0.080 |
Why?
|
| Medicare | 1 | 2013 | 426 | 0.080 |
Why?
|
| Cardia | 1 | 2009 | 27 | 0.080 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2009 | 24 | 0.080 |
Why?
|
| Fistula | 1 | 2009 | 49 | 0.080 |
Why?
|
| Sympathectomy | 1 | 2009 | 7 | 0.080 |
Why?
|
| Abdominal Abscess | 1 | 2009 | 24 | 0.080 |
Why?
|
| Hyperhidrosis | 1 | 2009 | 9 | 0.080 |
Why?
|
| Physicians | 1 | 2015 | 587 | 0.080 |
Why?
|
| Esophagus | 1 | 2010 | 221 | 0.080 |
Why?
|
| Talc | 1 | 1988 | 1 | 0.080 |
Why?
|
| Pleural Effusion | 1 | 2009 | 102 | 0.080 |
Why?
|
| Stents | 2 | 2012 | 888 | 0.070 |
Why?
|
| Surgical Procedures, Operative | 1 | 2010 | 184 | 0.070 |
Why?
|
| Suture Techniques | 1 | 2009 | 195 | 0.070 |
Why?
|
| Disease-Free Survival | 4 | 2011 | 899 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2008 | 206 | 0.070 |
Why?
|
| Fibrosis | 1 | 2009 | 434 | 0.070 |
Why?
|
| Polytetrafluoroethylene | 1 | 2008 | 83 | 0.070 |
Why?
|
| Carcinosarcoma | 1 | 2007 | 11 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 141 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2008 | 118 | 0.070 |
Why?
|
| Radiography | 1 | 2009 | 822 | 0.070 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2006 | 12 | 0.070 |
Why?
|
| Adolescent | 5 | 2019 | 19348 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2008 | 198 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2010 | 391 | 0.070 |
Why?
|
| Bile Ducts | 1 | 2006 | 53 | 0.070 |
Why?
|
| Minnesota | 3 | 2011 | 133 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2009 | 262 | 0.060 |
Why?
|
| Uterine Neoplasms | 1 | 2007 | 104 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2008 | 241 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2008 | 1114 | 0.060 |
Why?
|
| Equipment Design | 1 | 2008 | 599 | 0.060 |
Why?
|
| General Surgery | 1 | 2008 | 206 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 423 | 0.060 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2006 | 241 | 0.060 |
Why?
|
| Reference Values | 3 | 2009 | 715 | 0.060 |
Why?
|
| Comorbidity | 3 | 2016 | 1534 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2008 | 438 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2024 | 119 | 0.050 |
Why?
|
| Age Factors | 4 | 2012 | 2821 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 852 | 0.050 |
Why?
|
| Proportional Hazards Models | 3 | 2011 | 1361 | 0.050 |
Why?
|
| Cytokines | 1 | 2008 | 1288 | 0.050 |
Why?
|
| Curriculum | 1 | 2008 | 726 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 862 | 0.050 |
Why?
|
| Aerosols | 2 | 1994 | 65 | 0.050 |
Why?
|
| Sex Factors | 3 | 2012 | 1288 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2006 | 778 | 0.050 |
Why?
|
| Accreditation | 1 | 2021 | 88 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 285 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2016 | 6158 | 0.040 |
Why?
|
| Manometry | 1 | 2020 | 57 | 0.040 |
Why?
|
| Pentetic Acid | 2 | 1990 | 9 | 0.040 |
Why?
|
| Hospitals, Low-Volume | 1 | 2019 | 31 | 0.040 |
Why?
|
| Debridement | 2 | 2010 | 89 | 0.040 |
Why?
|
| Vital Capacity | 2 | 1990 | 76 | 0.040 |
Why?
|
| Bleomycin | 2 | 1989 | 154 | 0.040 |
Why?
|
| Forced Expiratory Volume | 2 | 1990 | 171 | 0.040 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2019 | 71 | 0.040 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 1989 | 87 | 0.040 |
Why?
|
| Radionuclide Imaging | 3 | 1994 | 149 | 0.040 |
Why?
|
| Solubility | 1 | 2017 | 139 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 1437 | 0.030 |
Why?
|
| Chromium Radioisotopes | 1 | 1997 | 4 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 1241 | 0.030 |
Why?
|
| Edetic Acid | 1 | 1997 | 23 | 0.030 |
Why?
|
| Iohexol | 1 | 1997 | 21 | 0.030 |
Why?
|
| Germany | 1 | 2016 | 65 | 0.030 |
Why?
|
| Causality | 1 | 2016 | 84 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2016 | 58 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1396 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 569 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2011 | 1327 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 348 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 377 | 0.030 |
Why?
|
| Employment | 1 | 2015 | 70 | 0.030 |
Why?
|
| Terbutaline | 1 | 1994 | 6 | 0.030 |
Why?
|
| Job Satisfaction | 1 | 2015 | 80 | 0.030 |
Why?
|
| Ventilation-Perfusion Ratio | 2 | 1985 | 5 | 0.030 |
Why?
|
| Peptides | 1 | 2017 | 811 | 0.030 |
Why?
|
| Algorithms | 2 | 2011 | 1629 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 506 | 0.030 |
Why?
|
| Catheter Ablation | 1 | 2016 | 233 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1271 | 0.030 |
Why?
|
| Forecasting | 1 | 2015 | 351 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 686 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1290 | 0.030 |
Why?
|
| Contrast Media | 1 | 1997 | 480 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2012 | 89 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 362 | 0.030 |
Why?
|
| Linear Models | 1 | 1994 | 683 | 0.020 |
Why?
|
| Vascular Fistula | 1 | 2012 | 31 | 0.020 |
Why?
|
| Apoptosis | 1 | 2019 | 1806 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1695 | 0.020 |
Why?
|
| Vinblastine | 2 | 1989 | 53 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 3348 | 0.020 |
Why?
|
| Gastrectomy | 1 | 2012 | 93 | 0.020 |
Why?
|
| Apgar Score | 1 | 2011 | 48 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 589 | 0.020 |
Why?
|
| Critical Pathways | 1 | 2011 | 77 | 0.020 |
Why?
|
| Organotechnetium Compounds | 1 | 1990 | 12 | 0.020 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1990 | 9 | 0.020 |
Why?
|
| Plants, Toxic | 1 | 1989 | 11 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 2012 | 200 | 0.020 |
Why?
|
| Mucus | 1 | 1989 | 36 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2455 | 0.020 |
Why?
|
| Logistic Models | 2 | 2012 | 1809 | 0.020 |
Why?
|
| Pleurodesis | 1 | 2009 | 16 | 0.020 |
Why?
|
| Technetium | 1 | 1989 | 12 | 0.020 |
Why?
|
| Chest Tubes | 1 | 2009 | 35 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2011 | 240 | 0.020 |
Why?
|
| Abscess | 1 | 2010 | 137 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2010 | 151 | 0.020 |
Why?
|
| Endoscopes | 1 | 2009 | 20 | 0.020 |
Why?
|
| Cause of Death | 1 | 2011 | 475 | 0.020 |
Why?
|
| Birth Weight | 1 | 2011 | 345 | 0.020 |
Why?
|
| Blastomycosis | 1 | 2008 | 6 | 0.020 |
Why?
|
| Total Lung Capacity | 1 | 1988 | 12 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 265 | 0.020 |
Why?
|
| Necrosis | 1 | 2009 | 207 | 0.020 |
Why?
|
| Regression Analysis | 2 | 1990 | 781 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1237 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2009 | 340 | 0.020 |
Why?
|
| Online Systems | 1 | 2008 | 13 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2008 | 44 | 0.020 |
Why?
|
| PubMed | 1 | 2008 | 20 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2008 | 32 | 0.020 |
Why?
|
| Osteomyelitis | 1 | 2010 | 207 | 0.020 |
Why?
|
| Computer-Assisted Instruction | 1 | 2008 | 51 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1994 | 2892 | 0.020 |
Why?
|
| Wound Healing | 1 | 2011 | 460 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 1988 | 132 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2007 | 144 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 197 | 0.020 |
Why?
|
| Gestational Age | 1 | 2011 | 1163 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2009 | 355 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2008 | 330 | 0.020 |
Why?
|
| Computers | 1 | 1986 | 68 | 0.020 |
Why?
|
| Mathematics | 1 | 1986 | 96 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2011 | 439 | 0.020 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2011 | 399 | 0.020 |
Why?
|
| Recurrence | 1 | 2009 | 1420 | 0.020 |
Why?
|
| Catheterization | 1 | 2006 | 235 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 475 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2008 | 372 | 0.010 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2011 | 615 | 0.010 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2012 | 804 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1988 | 1372 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 3300 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1990 | 874 | 0.010 |
Why?
|
| Kidney | 1 | 1988 | 1365 | 0.010 |
Why?
|
| Models, Biological | 1 | 1986 | 1460 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 2912 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 2 | 1997 | 504 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 1725 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2008 | 930 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 3090 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 1823 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 2430 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8209 | 0.010 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 1997 | 3 | 0.010 |
Why?
|
| Scintillation Counting | 1 | 1997 | 6 | 0.010 |
Why?
|
| Lung Volume Measurements | 2 | 1987 | 75 | 0.010 |
Why?
|
| Urography | 1 | 1997 | 31 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1997 | 144 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 248 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1983 | 1694 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2006 | 14010 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1985 | 1169 | 0.010 |
Why?
|
| Random Allocation | 1 | 1989 | 440 | 0.000 |
Why?
|
| Educational Status | 1 | 1989 | 276 | 0.000 |
Why?
|
| Alcohol Drinking | 1 | 1989 | 346 | 0.000 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1987 | 30 | 0.000 |
Why?
|
| Creatinine | 1 | 1988 | 389 | 0.000 |
Why?
|
| Child | 1 | 2006 | 24389 | 0.000 |
Why?
|
| Remission Induction | 1 | 1987 | 300 | 0.000 |
Why?
|
| Body Weight | 1 | 1990 | 989 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1990 | 1131 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1989 | 1195 | 0.000 |
Why?
|